Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7051 to 7065 of 7675 results

  1. Surgical vessel sealing systems (MT798)

    In development [GID-MT594] Expected publication date: TBC

    Medical technologies guidance
    In development

  2. VTS-270 for treating Niemann-Pick type C1 [ID1267]

    In development [GID-HST10020] Expected publication date: TBC

    Highly specialised technologies guidance
    In development

  3. Nivolumab in combination for treating hormone-relapsed metastatic prostate cancer before chemotherapy [ID1619]

    Discontinued [GID-TA10490]

    Technology appraisal guidance
    Discontinued

  4. Ibrutinib for treating relapsed or refractory follicular lymphoma and marginal zone lymphoma [ID1251]

    In development [GID-TA10525] Expected publication date: TBC

    Technology appraisal guidance
    In development

  5. Haemochromatosis

    Discontinued [GID-NG10287]

    NICE guideline
    Discontinued

  6. Acute bowel obstruction

    Discontinued [GID-NG10377]

    NICE guideline
    Discontinued

  7. Endometriosis: diagnosis and management - surgical management - pain management post-surgery

    Discontinued [GID-NG10385]

    NICE guideline
    Discontinued

  8. Breathlessness

    Discontinued [GID-NG10387]

    NICE guideline
    Discontinued

  9. Lower urinary tract symptoms in men, trans and non-binary people with a prostate: assessment and management (update)

    Discontinued [GID-NG10300]

    NICE guideline
    Discontinued

  10. Atopic Dermatitis (Eczema)

    Discontinued [GID-NG10289]

    NICE guideline
    Discontinued

  11. Lenadogene nolparvovec for treating Leber's hereditary optic neuropathy caused by the G11778A ND4 mitochondrial mutation [ID1410]

    In development [GID-TA10391] Expected publication date: TBC

    Technology appraisal guidance
    In development

  12. Surgical site infections: prevention and treatment - Update

    Discontinued [GID-NG10374]

    NICE guideline
    Discontinued

  13. Type 2 diabetes in adults: management - insulin therapy

    Discontinued [GID-NG10375]

    NICE guideline
    Discontinued

  14. Nivolumab for neoadjuvant and adjuvant treatment of localised renal cell carcinoma [ID4047]

    Discontinued [GID-TA10927]

    Technology appraisal guidance
    Discontinued

  15. Pegcetacoplan for amyotrophic lateral sclerosis TS ID 10594

    In development [GID-TA11310] Expected publication date: TBC

    Technology appraisal guidance
    In development